Analyze Diet
American journal of veterinary research2000; 61(9); 1011-1015; doi: 10.2460/ajvr.2000.61.1011

Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals.

Abstract: To determine effects of prior feeding on pharmacokinetics and estimated bioavailability of orally administered microencapsulated erythromycin base (MEB) in healthy foals. Methods: 6 healthy foals, 3 to 5 months old. Methods: Foals were given 2 doses of MEB (25 mg/kg of body weight, PO). One dose was administered after food was withheld overnight, and the other was administered after foals had consumed hay. The study used a crossover design with a 2-week period between doses. Blood was collected via a jugular vein prior to and at specific times after drug administration. Concentrations of erythromycin A and anhydroerythromycin A in plasma were determined, using high-performance liquid chromatography. Results pharmacokinetic analysis of plasma concentration-time data for food-withheld and fed conditions were compared. Results: Plasma concentrations of erythromycin A for foals were lower after feeding than concentrations when food was withheld. Area under the plasma concentration-time curve, maximum plasma concentration, and estimated bioavailability were greater in foals when food was withheld than when foals were fed. Anhydroerythromycin A was detected in plasma after administration of MEB in all foals. Conclusions: Foals should be given MEB before they are fed hay. Administration of MEB to foals from which food was withheld overnight apparently provides plasma concentrations of erythromycin A that exceed the minimum inhibitory concentration of Rhodococcus equi for approximately 5 hours. The dosage of 25 mg/kg every 8 hours, PO, appears appropriate.
Publication Date: 2000-09-08 PubMed ID: 10976728DOI: 10.2460/ajvr.2000.61.1011Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research analyzes how the timing of feeding affects the absorption and effectiveness of a single dose of orally administered microencapsulated erythromycin (an antibiotic) in young horses. It was found that administering the antibiotic to horses on an empty stomach results in a more effective absorption rate as opposed to when the horses have been fed beforehand.

Methodology

  • The study was conducted on 6 healthy foals aged between 3 to 5 months old.
  • The foals were administered two doses of microencapsulated erythromycin base (MEB), each dose consisting of 25 mg per kg of body weight.
  • As part of the crossover design of the study, one dose was given after food was withheld overnight (the foals were essentially fasting), while the other was administered after the foals had eaten hay.
  • A two-week period between doses was allowed for.
  • The researchers collected blood from the jugular vein of the horses before and at specific intervals after the administration of the drug.
  • High performance liquid chromatography was the method utilized to determine the levels of erythromycin A and its derivative, anhydroerythromycin A, in the plasma of the foals.

Results

  • In comparing the pharmacokinetic data (the way the drug moves within the body) for both the fed and unfed conditions for the horses, the study discovered that the plasma concentrations of erythromycin A were lower when the foals were fed before being given the drug.
  • Furthermore, data showed that the area under the plasma concentration-time curve, the maximum plasma concentration, and the estimated bioavailability of the drug were all greater when the horses were not fed before drug administration.
  • All foals showed traces of anhydroerythromycin A (a breakdown product of erythromycin) in their plasma after administration of MEB.

Conclusion

  • The study concludes that in order for the MEB to be more effective, it should be given to foals before they are fed hay.
  • Withholding food overnight before giving the medication results in plasma concentrations of erythromycin A that are above the minimum required to inhibit the growth of Rhodococcus equi (a bacterium that causes pneumonia in foals) for approximately 5 hours.
  • A dosage of 25 mg per kg body weight every 8 hours, orally, is recommended as a result of the findings of the study.

Cite This Article

APA
Lakritz J, Wilson WD, Marsh AE, Mihalyi JE. (2000). Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals. Am J Vet Res, 61(9), 1011-1015. https://doi.org/10.2460/ajvr.2000.61.1011

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 61
Issue: 9
Pages: 1011-1015

Researcher Affiliations

Lakritz, J
  • Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia 65211, USA.
Wilson, W D
    Marsh, A E
      Mihalyi, J E

        MeSH Terms

        • Administration, Oral
        • Animals
        • Anti-Bacterial Agents / administration & dosage
        • Anti-Bacterial Agents / pharmacokinetics
        • Biological Availability
        • Drug Compounding / veterinary
        • Erythromycin / administration & dosage
        • Erythromycin / pharmacokinetics
        • Horses / metabolism
        • Male

        Citations

        This article has been cited 1 times.
        1. Zozaya H, Gutierrez L, Bernad MJ, Sumano H. Pharmacokinetics of a peroral single dose of two long-acting formulations and an aqueous formulation of doxycycline hyclate in horses. Acta Vet Scand 2013 Mar 8;55(1):21.
          doi: 10.1186/1751-0147-55-21pubmed: 23497696google scholar: lookup